First Manhattan’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

First Manhattan’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3	Closed	-$383	–	1713
2022 Q4	$383	Hold	3	–	–	﹤0.01%	1619
2022 Q3	$0	Hold	3	–	–	﹤0.01%	1665
2022 Q2	$0	Hold	3	–	–	﹤0.01%	1680
2022 Q1	$1K	Hold	3	–	–	﹤0.01%	1564
2021 Q4	$2K	Hold	3	–	–	﹤0.01%	1494
2021 Q3	$3K	Sell	3 -3	-50%	-$5.82K	﹤0.01%	1498
2021 Q2	$18K	Hold	6	–	–	﹤0.01%	1178
2021 Q1	$36K	Hold	6	–	–	﹤0.01%	1028
2020 Q4	$33K	Sell	6 -1	-14%	-$6.28K	﹤0.01%	975
2020 Q3	$40K	Sell	7 -6	-46%	-$35K	﹤0.01%	916
2020 Q2	$79K	Buy	+13	New	+$88K	﹤0.01%	811
2020 Q1	–	Sell	-602	Closed	-$10.1M	–	1466
2019 Q4	$10.1M	Sell	602 -2	-0.3%	-$33.3K	0.05%	166
2019 Q3	$9.74M	Sell	604 -14	-2%	-$226K	0.05%	166
2019 Q2	$13.3M	Sell	618 -9	-1%	-$223K	0.07%	137
2019 Q1	$17.7M	Buy	627 +259	+70%	+$6.22M	0.1%	112
2018 Q4	$5.46M	Buy	368 +105	+40%	+$2.35M	0.03%	228
2018 Q3	$9.33M	Buy	263 +255	+3,188%	+$7.87M	0.05%	196
2018 Q2	$248K	Buy	+8	New	+$311K	﹤0.01%	660

Other funds holding YARW

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

First Manhattan's YARW Position: Q1 2023 in Review

First Manhattan sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2023, closing a stake of 3 shares — an estimated $383 sold.

First Manhattan first reported a position in YARW in Q2 2018 and held it in 18 quarters. The position peaked at $17.7M in Q1 2019. 21 funds tracked by Wall St. Rank hold YARW as of Q1 2023.

First Manhattan reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
First Manhattan sold 3 Yarrow Bioscience, Inc. Common Stock shares in Q1 2023, an estimated $383.
First Manhattan first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2018 and held it in 18 quarters.
First Manhattan's Yarrow Bioscience, Inc. Common Stock position peaked at $17.7M in Q1 2019.
21 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2023.

Based on First Manhattan's 13F filing for Q1 2023, filed 15 May 2023.